» Articles » PMID: 34621853

Exophiala Dermatitidis

Abstract

is a genus comprising several species of opportunistic black yeasts, which belongs to Ascomycotina. It is a rare cause of fungal infections. However, infections are often chronic and recalcitrant, and while the number of cases is steadily increasing in both immunocompromised and immunocompetent people, detailed knowledge remains scarce regarding infection mechanisms, virulence factors, specific predisposing factors, risk factors, and host response. The most common manifestations of infection are skin infections, and the most frequent type of deep infection is pulmonary infection due to inhalation. The invasive disease ranges from cutaneous or subcutaneous infection to systemic dissemination to internal organs. The final identification of the causative organism should be achieved through a combination of several methods, including the newly introduced diagnostic analysis, matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry, together with sequencing of the ribosomal ribonucleic acid internal transcribed spacer region of the fungi, and histological and culture findings. Regarding treatment, because anti-infective agents and natural compounds exhibited poor antibiofilm activity, few treatments have ultimately been found to be effective for specific antifungal therapy, so the optimal antifungal therapy and duration of therapy for these infections remain unknown. Therefore, most forms of disease caused by require aggressive combination therapies: Both surgical intervention and aggressive antifungal therapy with novel compounds and azoles are necessary for effective treatment.

Citing Articles

Polyextremotolerant, opportunistic, and melanin-driven resilient black yeast Exophiala dermatitidis in environmental and clinical contexts.

de Leon L, Moreno-Perlin T, Castillo-Marenco T, Del Rayo Sanchez-Carbente M, Gostincar C, Ramirez-Duran N Sci Rep. 2025; 15(1):6472.

PMID: 39987208 PMC: 11846982. DOI: 10.1038/s41598-025-88595-z.


Development of PCR-Multiplex Assays for Identification of the Herpotrichiellaceae Family and Agents Causing Chromoblastomycosis.

Sousa G, De Oliveira R, Souza A, Monteiro R, Santo E, Franco Filho L J Fungi (Basel). 2024; 10(8).

PMID: 39194874 PMC: 11355602. DOI: 10.3390/jof10080548.


Exophiala species in household environments and their antifungal resistance profile.

Kondori N, Jaen-Luchoro D, Karlsson R, Abedzaedeh B, Hammarstrom H, Jonsson B Sci Rep. 2024; 14(1):17622.

PMID: 39085337 PMC: 11291800. DOI: 10.1038/s41598-024-68166-4.


Exploring a Rare Pulmonary Coinfection: Cryptococcal Pneumonia and Exophiala dermatitidis in an Immunocompetent Host.

Kohli A, Rifai Z, Foray N Cureus. 2024; 16(5):e61085.

PMID: 38919216 PMC: 11197632. DOI: 10.7759/cureus.61085.


Identification of Chromoblastomycosis and Phaeohyphomycosis Agents through ITS-RFLP.

Sousa G, De Oliveira R, De Souza A, Monteiro R, Santo E, Franco Filho L J Fungi (Basel). 2024; 10(2).

PMID: 38392831 PMC: 10890301. DOI: 10.3390/jof10020159.


References
1.
Brandt M, Warnock D . Epidemiology, clinical manifestations, and therapy of infections caused by dematiaceous fungi. J Chemother. 2004; 15 Suppl 2:36-47. DOI: 10.1179/joc.2003.15.Supplement-2.36. View

2.
Kumar A, Nandakumar A, Nair S, Singh A, Shashindran N, Thulasidharan S . Exophiala dermatitidis as a cause of central line associated bloodstream infection in an infant: Case report and literature review. Rev Iberoam Micol. 2020; 38(1):12-15. DOI: 10.1016/j.riam.2020.09.004. View

3.
Ozhak-Baysan B, Ogunc D, Dogen A, Ilkit M, de Hoog G . MALDI-TOF MS-based identification of black yeasts of the genus Exophiala. Med Mycol. 2015; 53(4):347-52. DOI: 10.1093/mmy/myu093. View

4.
Gao L, Sun Y, He C, Li M, Zeng T . In vitro interactions between 17-AAG and azoles against Exophiala dermatitidis. Mycoses. 2018; 61(11):853-856. DOI: 10.1111/myc.12824. View

5.
Yazdanparast S, Mohseni S, de Hoog G, Aslani N, Sadeh A, Badali H . Consistent high prevalence of Exophiala dermatitidis, a neurotropic opportunist, on railway sleepers. J Mycol Med. 2017; 27(2):180-187. DOI: 10.1016/j.mycmed.2017.01.007. View